BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29057309)

  • 21. Total recall: the role of PIDDosome components in neurodegeneration.
    Volik PI; Kopeina GS; Zhivotovsky B; Zamaraev AV
    Trends Mol Med; 2023 Dec; 29(12):996-1013. PubMed ID: 37716905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.
    Xian J; Shao H; Chen X; Zhang S; Quan J; Zou Q; Jin H; Zhang L
    Int J Biol Sci; 2016; 12(2):144-55. PubMed ID: 26884713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Janus-faced PIDD: a sensor for DNA damage-induced cell death or survival?
    McCoy F; Eckard L; Nutt LK
    Mol Cell; 2012 Sep; 47(5):667-8. PubMed ID: 22980457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
    Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
    Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
    Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
    Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
    Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
    ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin.
    Ziv O; Zeisel A; Mirlas-Neisberg N; Swain U; Nevo R; Ben-Chetrit N; Martelli MP; Rossi R; Schiesser S; Canman CE; Carell T; Geacintov NE; Falini B; Domany E; Livneh Z
    Nat Commun; 2014 Nov; 5():5437. PubMed ID: 25421715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural investigation of nucleophosmin interaction with the tumor suppressor Fbw7γ.
    Di Matteo A; Franceschini M; Paiardini A; Grottesi A; Chiarella S; Rocchio S; Di Natale C; Marasco D; Vitagliano L; Travaglini-Allocatelli C; Federici L
    Oncogenesis; 2017 Sep; 6(9):e379. PubMed ID: 28920929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of mutation effects on PIDDosome core complex.
    Jang TH; Seo EK; Park HH
    Appl Biochem Biotechnol; 2013 May; 170(1):210-8. PubMed ID: 23494218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleolar caspase-2: Protecting us from DNA damage.
    O'Byrne KJ; Richard DJ
    J Cell Biol; 2017 Jun; 216(6):1521-1523. PubMed ID: 28500181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
    Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
    Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
    Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis.
    Olsson M; Vakifahmetoglu H; Abruzzo PM; Högstrand K; Grandien A; Zhivotovsky B
    Oncogene; 2009 May; 28(18):1949-59. PubMed ID: 19347032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia.
    Forghieri F; Riva G; Lagreca I; Barozzi P; Vallerini D; Morselli M; Paolini A; Bresciani P; Colaci E; Maccaferri M; Gilioli A; Nasillo V; Messerotti A; Pioli V; Arletti L; Giusti D; Bettelli F; Celli M; Donatelli F; Corradini G; Basso S; Gurrado A; Cellini M; Trenti T; Marasca R; Narni F; Martelli MP; Falini B; Potenza L; Luppi M; Comoli P
    Oncotarget; 2019 Jan; 10(8):869-882. PubMed ID: 30783516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N6L pseudopeptide interferes with nucleophosmin protein-protein interactions and sensitizes leukemic cells to chemotherapy.
    De Cola A; Franceschini M; Di Matteo A; Colotti G; Celani R; Clemente E; Ippoliti R; Cimini AM; Dhez AC; Vallée B; Raineri F; Cascone I; Destouches D; De Laurenzi V; Courty J; Federici L
    Cancer Lett; 2018 Jan; 412():272-282. PubMed ID: 29111347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of NPM1 type B mutation on the proliferation, invasion and chemosensitivity of THP-1 leukemia cells.
    Peng J; Fu B; Fu G; Zhao X; Li X; Chen F
    Pharmazie; 2017 Oct; 72(10):608-613. PubMed ID: 29441887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The resurrection of the PIDDosome - emerging roles in the DNA-damage response and centrosome surveillance.
    Sladky V; Schuler F; Fava LL; Villunger A
    J Cell Sci; 2017 Nov; 130(22):3779-3787. PubMed ID: 29142064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human nucleophosmin 1 mutation A inhibits myeloid differentiation of leukemia cells by modulating miR-10b.
    Zou Q; Tan S; Yang Z; Wang J; Xian J; Zhang S; Jin H; Yang L; Wang L; Zhang L
    Oncotarget; 2016 Nov; 7(44):71477-71490. PubMed ID: 27669739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When the good go bad: Mutant NPM1 in acute myeloid leukemia.
    Kunchala P; Kuravi S; Jensen R; McGuirk J; Balusu R
    Blood Rev; 2018 May; 32(3):167-183. PubMed ID: 29157973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.
    Rezaei N; Arandi N; Valibeigi B; Haghpanah S; Khansalar M; Ramzi M
    Turk J Haematol; 2017 Dec; 34(4):300-306. PubMed ID: 28294102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.